2020
DOI: 10.1002/cbf.3486
|View full text |Cite
|
Sign up to set email alerts
|

Circ_LAS1L regulates cardiac fibroblast activation, growth, and migration through miR‐125b/SFRP5 pathway

Abstract: Funding informationThis work was supported by the young teachers program of Beijing university of Chinese medicine (2018-JYBZZ-JS094) and the scientific research project of Sichuan health committee (19PJ214).Current studies have shown that circular RNAs (circRNAs) and microRNAs (miRNAs) are closely related in acute myocardial infarction (AMI). Previous studies have shown that miR-125b promotes fibrosis and up-regulates in cardiac fibroblasts (CFs), and further experiments showed that circ_LAS1L had multiple bi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(27 citation statements)
references
References 23 publications
(27 reference statements)
1
24
0
Order By: Relevance
“…circRNAs miR-125b induces fibrotic process and upregulation in CFs, indicating numerous binding sites of miR-125b for circ_LAS1L, with inverse association of their expression in those with acute myocardial infarction (AMI) and CFs. RNA immunoprecipitation (RIP), pull-down, and dual-luciferase reporter gene assay supported direct binding of miR-125b bound to circ_LAS1L (114). Overexpressed Circ_LAS1L led to promotion of the downstream target gene secreted frizzledassociated protein 5 (SFRP5) expressions, while reducing α-SMA, collagen I, and collagen III expression; hindering CF proliferation and migration; and increasing apoptosis.…”
Section: Long Non-codingmentioning
confidence: 92%
See 1 more Smart Citation
“…circRNAs miR-125b induces fibrotic process and upregulation in CFs, indicating numerous binding sites of miR-125b for circ_LAS1L, with inverse association of their expression in those with acute myocardial infarction (AMI) and CFs. RNA immunoprecipitation (RIP), pull-down, and dual-luciferase reporter gene assay supported direct binding of miR-125b bound to circ_LAS1L (114). Overexpressed Circ_LAS1L led to promotion of the downstream target gene secreted frizzledassociated protein 5 (SFRP5) expressions, while reducing α-SMA, collagen I, and collagen III expression; hindering CF proliferation and migration; and increasing apoptosis.…”
Section: Long Non-codingmentioning
confidence: 92%
“…Sun et al investigated that circ_LAS1L in those suffering AMI and CFs was downregulated and was capable of direct binding to miR-125b, consequently enhancing the downstream target gene secreted frizzled-related protein 5 (SFRP5) expression, finally repressing CF activating, proliferating, and migrating, along with inducing apoptosis. Thus, it is has been posited that the circ_LAS1L/miR-125b/SFRP5 pathway is capable of modulating the biological characteristics of CF and can contribute vitally to the process of cardiac fibrosis, therefore offering a significant theoretical basis to regulate cardiac fibrotic event following myocardial infarction (114).…”
Section: Long Non-codingmentioning
confidence: 99%
“…Silencing circRNA 010567 in the rat model of acute MI established that using ligation of the left anterior descending coronary artery would improve cardiac function, higher ejection fraction, and fractional shortening and alleviate MF through the TGF-b1 signaling pathway (Bai et al, 2020). A cardioprotective circRNA, circ_LAS1L, was found markedly downregulated in acute MI (Sun L. Y. et al, 2020). Overexpression of circ_LAS1L could inhibit cardiac fibroblast proliferation and migration and promote apoptosis.…”
Section: Circrnas In Hfmentioning
confidence: 93%
“…[50][51][52][53] Additionally, studies from Sun et al elucidated that CF activation and proliferation can be regulated by cytoplasmic circLAS1L via the miR-125b/SFRP5 pathway. 54 These discoveries lead to the question whether exosomal circRNAs are also involved in CF activation and warrant further investigation. If exosomal circRNA is involved, novel therapeutic strategies could be developed by using artificial circRNA-enriched exosomes.…”
Section: Cardiopathymentioning
confidence: 99%